Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 36 Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 3 Lymphoma, Mantle-Cell 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Advanced Breast Cancer 3 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Inflammation 2 Hereditary Sensory and Autonomic Neuropathies 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Thromboembolism 1 Thrombocytosis 1 Squamous Cell Carcinoma of Head and Neck 1 Primary Myelofibrosis 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Myeloproliferative Disorders 1

Interventions

venetoclax 1 palbociclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Neoplasm Female × palbociclib × Clear all

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡